AU2005212123A1 - Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal - Google Patents

Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal Download PDF

Info

Publication number
AU2005212123A1
AU2005212123A1 AU2005212123A AU2005212123A AU2005212123A1 AU 2005212123 A1 AU2005212123 A1 AU 2005212123A1 AU 2005212123 A AU2005212123 A AU 2005212123A AU 2005212123 A AU2005212123 A AU 2005212123A AU 2005212123 A1 AU2005212123 A1 AU 2005212123A1
Authority
AU
Australia
Prior art keywords
administered
vitamin
cow
administration
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005212123A
Other languages
English (en)
Inventor
Yoshihisa Naito
Norimoto Okura
Norio Yamagishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mercian Corp
Original Assignee
Mercian Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mercian Corp filed Critical Mercian Corp
Publication of AU2005212123A1 publication Critical patent/AU2005212123A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2005212123A 2004-02-18 2005-02-17 Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal Abandoned AU2005212123A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004-041202 2004-02-18
JP2004041202 2004-02-18
PCT/JP2005/002959 WO2005077378A1 (fr) 2004-02-18 2005-02-17 Procédé consistant à prévenir, médicamenter et/ou traiter l'hypocalcémie chez un mammifère domestique

Publications (1)

Publication Number Publication Date
AU2005212123A1 true AU2005212123A1 (en) 2005-08-25

Family

ID=34857917

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005212123A Abandoned AU2005212123A1 (en) 2004-02-18 2005-02-17 Method of preventing, medicating and/or treating hypocalcaemia of domestic mammal

Country Status (6)

Country Link
US (1) US20060270640A1 (fr)
EP (1) EP1719513A4 (fr)
JP (1) JPWO2005077378A1 (fr)
AU (1) AU2005212123A1 (fr)
CA (1) CA2556405A1 (fr)
WO (1) WO2005077378A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2440213B1 (fr) 2009-06-10 2013-11-06 Emma ® Nutrition Utilisation d'1,25-dihydroxyvitamine D3 glycosides chez des animaux producteurs de lait
US20230248761A1 (en) * 2022-02-10 2023-08-10 Contract Manufacturing Services, LLC Method for supporting normal blood calcium concentrations in mammals

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4670190A (en) * 1973-01-10 1987-06-02 Hesse Robert H 1-α-hydroxy vitamin D compounds and process for preparing same
ZA74158B (en) * 1973-01-10 1975-03-26 Res Inst Medicine Chem Chemical process
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US5472957A (en) * 1973-01-10 1995-12-05 Research Institute For Medicine And Chemistry Chemical compounds and process
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
RO105130B1 (ro) * 1987-12-14 1995-10-01 Inst Medicina Farmacie Preparat vaginal sub formă de ovule
CA1341408C (fr) * 1988-08-02 2002-12-10 Charles W. Bishop Methode de prevention et de traitement de la perte de masse osseuse
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
NZ228382A (en) * 1989-03-17 1992-08-26 Carter Holt Harvey Plastic Pro Drug administering coil-like device for insertion in body cavity of animal
NZ286492A (en) * 1996-05-01 1998-02-26 Dec International Nz Ltd Subst Intra vaginal devices for synchronising oestrus of animals is made up of cured silicone rubber material with 5% by weight of progesterone
AU5783898A (en) * 1997-02-03 1998-08-25 Dec International Nz Limited Active delivery device and related procedures
US6572874B1 (en) * 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US7033996B2 (en) * 2001-08-31 2006-04-25 University Of Medicine & Dentistry Of New Jersey Method for the treatment of vitamin D related disease
US6905901B1 (en) * 2002-03-27 2005-06-14 Delphi Technologies, Inc. Method of manufacturing a cover of a backlit display using fluorescing materials

Also Published As

Publication number Publication date
EP1719513A4 (fr) 2009-05-13
JPWO2005077378A1 (ja) 2007-10-18
CA2556405A1 (fr) 2005-08-25
WO2005077378A1 (fr) 2005-08-25
US20060270640A1 (en) 2006-11-30
EP1719513A1 (fr) 2006-11-08

Similar Documents

Publication Publication Date Title
Baggot et al. Basis for selection of the dosage form
AU2003267131A1 (en) Formulation for lipophilic agents
AU2013281217B2 (en) Use of 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism
JP7441946B2 (ja) 非ヒト動物の乾乳におけるｓｇｌｔ－２阻害剤の使用
Choe et al. Absorption of oral thyroxine
US20060270640A1 (en) Method of preventing, medicating, and/or treating hypocalcemia of domestic mammal
US20200138823A1 (en) Drug compositions
CN111467391B (zh) 香叶基黄酮a在制备促进伤口愈合的药物中的用途
EP2490667B1 (fr) Composition contenant solanum glaucophyllum destinée à la prévention et/ou au traitement de l'hypocalcémie et à la stabilisation des niveaux de calcium dans le sang
AU716492B2 (en) Somatotropin compositions mixed with vitamins
Coil et al. Altered host response to experimental pyelonephritis in alloxan diabetic rats
De Risio Reactive seizures
Bastani et al. Oxalate kinetics and reversal of the complications after orthotopic liver transplantation in a patient with primary hyperoxalosis type 1 awaiting renal transplantation
CA2207028A1 (fr) Trousse pour cycle de traitement de l'osteoporose
Geiger et al. Effects of Gastro-Intestinal Resections in Swine on the Anti-Anemia Potency of the Liver: With Observations on the Nature and Sources of the Materials Effective in Pernicious Anemia
Shani et al. Interspecies study on the effect of perphenazine on milk yield and composition
EP4208160A1 (fr) Formulations de liquides ioniques de traitement du diabète
Nieuwoudt et al. Pharmacokinetics and stability of an enrofloxacin oral gel formulation in horses.
JPH0377173B2 (fr)
JPS63248353A (ja) エストリオール成長促進剤
CN117462527A (zh) 甲磺酸加贝酯在制备治疗宠物胰腺炎的药物中的应用
Patra et al. Sacolene in cholera: a double blind randomized controlled trial
Shue An examination of prostaglandins as causative agents in pine needle (Pinus ponderosa) abortion
Kyle et al. Use of ACTH and adrenocortical hormone therapy for protection against operative trauma
JPH04279522A (ja) 血清カルシウム濃度調整薬

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application